Inventor · disambiguated record
Paul Maes
Also filed as: MAES PAUL · MAES PAUL JOSE' PIERRE MARIE
17 granted patents·10 pending applications·838 citations·filing 2003–2024
96Inventor score
Files withBIOVAIL LAB INT SRL20OBEREGGER WERNER2ACERUS BIOPHARMA INC1JACKSON GRAHAM1VALEANT INTERNAT BERMUDA1
Top patents by PatentIndex Score
27 records- 0198US7884136B2Modified-release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2006·Granted Feb 8, 2011·135 cites·4 claims
- 0298US7579380B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Aug 25, 2009·135 cites·20 claims
- 0398US7569610B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Aug 4, 2009·144 cites·5 claims
- 0498US7569611B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Aug 4, 2009·141 cites·8 claims
- 0598US7241805B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2006·Granted Jul 10, 2007·79 cites·9 claims
- 0696US8932628B2Modified release formulations of a bupropion saltOBEREGGER WERNER·Filed 2007·Granted Jan 13, 2015·130 cites·10 claims
- 0792US7553992B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Jun 30, 2009·11 cites·3 claims
- 0891US7585897B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Sep 8, 2009·9 cites·15 claims
- 0990US7572935B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Aug 11, 2009·7 cites·3 claims
- 1088US7662407B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Feb 16, 2010·5 cites·5 claims
- 1188US7645901B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Jan 12, 2010·5 cites·3 claims
- 1288US7563823B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Jul 21, 2009·6 cites·14 claims
- 1387US7649019B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Jan 19, 2010·5 cites·3 claims
- 1486US7645802B2Bupropion hydrobromide and therapeutic applicationsBIOVAIL LAB INT SRL·Filed 2007·Granted Jan 12, 2010·7 cites·15 claims
- 1583US7780987B2Controlled release dosage formsBIOVAIL LAB INT SRL·Filed 2003·Granted Aug 24, 2010·16 cites·6 claims
- 1676US2025064831A1Controlled release topical testosterone formulations and methodsACERUS BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1772US9504640B2Modified release formulations of a bupropion saltVALEANT PHARMACEUTICALS LUXEMBOURG S Á R L·Filed 2014·Granted Nov 29, 2016·1 cites·11 claims
- 1871US7537784B2Modified release tablet of bupropion hydrochlorideBIOVAIL LAB INT SRL·Filed 2006·Granted May 26, 2009·2 cites·16 claims
- 1970US2009269402A1Modified release composition of at least one form of venlafaxineBIOVAIL LAB INT SRL·Filed 2009·Application pending·0 cites
- 2066US2008175873A1Modified release composition of at least one form of venlafaxineBIOVAIL LAB INT SRL·Filed 2007·Application pending·0 cites
- 2163US2008274177A1Controlled release dosage formsBIOVAIL LAB INT SRL·Filed 2008·Application pending·0 cites
- 2262US2007098797A1Modified release composition of at least one form of venlafaxineBIOVAIL LAB INT SRL·Filed 2006·Application pending·0 cites
- 2362US2010255094A1Bupropion hydrobromide and therapeutic applicationsBIOVAIL LAB INT SRL·Filed 2008·Application pending·0 cites
- 2456US2013245154A1Controlled release dosage formsZHOU FANG·Filed 2013·Application pending·0 cites
- 2556US2015030675A1Controlled Release Dosage FormsVALEANT INTERNAT BERMUDA·Filed 2014·Application pending·0 cites
- 2653US2013266650A1Bupropion hydrobromide and therapeutic applicationsJACKSON GRAHAM·Filed 2013·Application pending·0 cites
- 2744US2005238718A1Modified-release tablet of bupropion hydrochlorideOBEREGGER WERNER·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Maes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →